Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01178853 · ClinicalTrials.gov registry record · Phase 4
Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers
A Phase 4 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT01178853 is a Phase 4 study that has completed, run by Kowa Research Institute. The registered enrollment target is 48 participants.
The verdict
NCT01178853, a Phase 4 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
This is a Phase 4, single center, open label, 4 period, 2 treatment, crossover, drug-drug interaction study.
Interventions
- DRUG Warfarin
- DRUG Warfarin 5mg + Rosuvastatin 40 mg once daily (QD)
- DRUG Warfarin 5 mg + Pitavastatin 4mg once daily (QD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01178853
The ClinicalTrials.gov registry entry for NCT01178853 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Warfarin is the first listed.
NCT01178853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01178853 about?
NCT01178853 is a clinical study titled "Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers". This is a Phase 4, single center, open label, 4 period, 2 treatment, crossover, drug-drug interaction study.
What is the current status of trial NCT01178853?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2010-07. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01178853?
The interventions under investigation include: Warfarin (DRUG), Warfarin 5mg + Rosuvastatin 40 mg once daily (QD) (DRUG), Warfarin 5 mg + Pitavastatin 4mg once daily (QD) (DRUG).
Who is sponsoring clinical trial NCT01178853?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.